Whether you’re fighting off a winter cold or seasonal allergies, experts share how to find some relief.
Phase 3 LIBERTY-AIMS results showed dupilumab reduced nasal polyp size and sinus symptoms in adults and children with allergic fungal rhinosinusitis.
The FDA has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis.
Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.
Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to ...
Holi celebrations bring colours, water games and loud festivities, but children with ear, nose and throat conditions may face ...
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients ...
Allergic rhinitis (commonly known as hay fever) affects around 20% of Australians Grass and weed pollens can persist from August to ...
New appointment strengthens executive leadership commensurate with launch of CARDAMYST™ (etripamil) nasal sprayMONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals ...
Scientists in the United States say they may be inching closer to a long-sought goal in medicine: a single vaccine capable of ...
The new GLA-3M-052-LS+OVA vaccine can be delivered as a nasal spray. Three doses protected mice from infection from ...
Imagine a nasal spray that could stop you from getting sick. Researchers in Maryland are testing an experimental treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results